Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08VDM
|
|||
| Former ID |
DNCL001991
|
|||
| Drug Name |
AZD4694
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Alzheimer disease [ICD-11: 8A20; ICD-10: G30, G30.9; ICD-9: 331] | Phase 2 | [1] | |
| Company |
Navidea Biopharmaceuticals
|
|||
| Structure |
 |
Download2D MOL |
||
| Canonical SMILES |
CNC1=NC(=C(CC1)C2=CC3=C(O2)C=CC(=C3)O)F
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00991419) To Compare Positron Emission Tomography (PET) Measurements of Fibrillar Amyloid Burden. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.